• 1
    Schantz PS. Experimental head and neck oncology. Curr Opinions Oncol 1991; 3: 5006.
  • 2
    Carter LR. Pathology of squamous carcinomas of the head and neck. Curr Opinions Oncol 1991; 3: 50711.
  • 3
    Davis RK. Prognostic variables in head and neck cancer: tumor site, stage, nodal status, differentiation, and immune status. Otolaryngol Clin North Am 1985; 18: 4119.
  • 4
    Franceschi S, Talamini R, Barra S, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in Northern Italy. Cancer Res 1990; 50: 65027.
  • 5
    Heim S, Mitelman F. Numerical chromosome aberrations in human neoplasia. Cancer Genet Cytogenet 1986; 22: 99108.
  • 6
    Teyssier JR. The chromosomal analysis of human solid tumors: a triple challenge. Cancer Genet Cytogenet 1989; 37: 10325.
  • 7
    Sandberg AA, Turc-Carel C. The cytogenetics of solid tumors: relation to diagnosis, classification and pathology. Cancer 1987; 59: 38795.
  • 8
    Pathal S. Cytogenetics of epithelial malignant lesions. Cancer 1992; 70: 166070.
  • 9
    Chan VTW, McGee JO. Cellular oncogenes in neoplasia J Clin Pathol 1987; 40: 105563.
  • 10
    Renan MJ. Cancer genes: current status, future prospects, and applications in radiotherapy oncology. Radiother Oncol 1990; 19: 197218.
  • 11
    Schwab M. Oncogene amplification in neoplastic development and progression of human cancers. Oncogenesis 1990; 2: 3551.
  • 12
    Lebovitz RM, Albrecht S. Molecular biology in the diagnosis and prognosis of solid and lymphoid tumor. Cancer Invest 1992; 10: 399416.
  • 13
    Osella P, Carlson A, Wyandt H, Milunsky A. Cytogenetic studies of eight squamous cell carcinomas of the head and neck: deletion of 7, a possible primary chromosomal event. Cancer Genet Cytogenet 1992; 59: 738.
  • 14
    Zaslav A-L, Stamberg J, Steinberg BM, Lin YJ, Abramson A. Cytogenetic analysis of head and neck carcinomas. Cancer Genet Cytogenet 1991; 56: 1817.
  • 15
    Hanser-Urfer IF, Stauffer J. Comparative chromosome analysis of nine squamous cell carcinoma cell lines from tumor of the head and neck. Cytogenet Cell Genet 1985; 39: 359.
  • 16
    Sacks PG, Parnes SM, Gallick GE, Lichtner R, Pathak S, Parsons DF. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res 1988; 48: 285866.
  • 17
    Heo DS, Snyderman C, Gollin SM, Pan S, Walker E, Deka R, et al. Biology, cytogenetics, sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 1989; 49: 516775.
  • 18
    Cowen JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst 1992; 48: 7937.
  • 19
    Jin Y, Mandahl N, Heim S, Biörklund A, Wennerberg J, Mitelman F. Unique karyotypic abnormalities in a squamous cell carcinoma of the larynx. Cancer Genet Cytogenet 1988; 32: 3057.
  • 20
    Jin Y, Higashi K, Mandahl N, Heim S, Wernerberg J, Biörklund A, et al. Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinoma of the head and neck. Genes Chromosomes and Cancer 1990; 2: 198204.
  • 21
    Worsham MJ, Van Dyke DL, Benninger MS. Consistent chromosome changes in 15 squamous cell carcinomas of the head and neck. Am J Hum Genet 1990; 47: A24.
  • 22
    Kawasaki ES. The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers. Cancer Invest 1992; 10: 41729.
  • 23
    Branch H, Johnson B, Hovis J, Yano T, Gazdar A, Pettengill OS, et al. Molecular analysis of the short arm of chromosome 3 in small cell and non-small-cell carcinoma of the lung. N Engl J Med 1987; 317: 110913.
  • 24
    Daly MC, Douglas JB, Bleehen NM, Hasleton P, Twentyman PR, Sundaresan V, et al. An unusually proximal deletion on the short arm of chromosome 3 in a patient with small cell lung cancer. Genomics 1991; 9: 1139.
  • 25
    Rabbitts P, Douglas J, Daly M, Sundaresan V, Fox B, Hasleton P, et al. Frequency and extent of allelic loss in the short arm of chromosome 3 in non-small-cell lung cancer. Genes Chromosom Cancer 1989; 1: 95105.
  • 26
    Yokota J, Wada M, Shimosata Y, Terada M, Sugimura T. Loss of heterozygosity on chromosome 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 1987; 84: 92526.
  • 27
    Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosato Y, Mori N, et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 1989; 49: 3598601.
  • 28
    Houst AHVD, Vlies FVD, Wijmenga C, Li FP, Oosterhuis JW, Buys CHCM. The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB. Genomics 1992; 11: 53742.
  • 29
    Bergerheim U, Nordenskjöld M, Collius VP. Deletion mapping in human renal cell carcinoma. Cancer Res 1989; 49: 13906.
  • 30
    Erlandsson R, Bergerheim USR, Boldog F, Marcsek Z, Kunimi K, Lin BYT, et al. A gene near the D3F15S2 site on 3p is expressed in normal kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC). Oncogene 1990; 5: 120711.
  • 31
    Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Müller-Brechlin R, Klein G, et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A 1988; 85: 15715.
  • 32
    Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991; 51: 10717.
  • 33
    Latif F, Fivash M, Glenn G, Tory K, Orcutt MC, Hampsch K, et al. Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss. Cancer Res 1992; 52: 14516.
  • 34
    World Health Organization. Histological typing of upper respiratory tract tumors. In: ShanmugaratnamK, SobinLH, editors. International histological classification of tumors, no. 19. Geneva: World Health Organization, 1978: 14.
  • 35
    Traganos F, Darzynkiewicz Z, Sharpless T, Melamed MR. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. J Histochem Cytochem 1977; 25: 4656.
  • 36
    Feinberg AP, Vogelstein B. A technique for radio-labelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 613.
  • 37
    Geiser AG, Stanbridge EJ. A review of the evidence for tumor suppressor genes. Crit Rev Oncol Hematol 1989; 1: 26176.
  • 38
    Heppell-Parton AC, Albertson DG, Rabbitts PH. Ordering of six polymorphic DNA markers important in the delineation of 3p deletions in neoplasia. Genes Chromosomes and Cancer 1992; 4: 22834.
  • 39
    Merlo GR, Cropp CS, Callahan R, Takahashi T. Detection of loss of heterozygosity in tumor DNA samples by PCR. Biotechniques 1991; 11: 1668.
  • 40
    Ganly PS, Jarad N, Rudd RM, Rabbitts PH. PCR-based RFLP analysis allows genotyping of the short arm of chromosome 3 in small biopsies from patients with lung cancer. Genomics 1992; 12: 2218.
  • 41
    Merlo GR, Venesio T, Bernardi A, Carole L, Gaglia P, Lauro D, et al. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumor with high proliferation index. Am J Pathol 1992; 140: 21523.
  • 42
    Suchy B, Zietz C, Rabes HM. K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis. Int J Cancer 1992; 52: 303.
  • 43
    Meling GI, Lothe RA, Borresen A-L, et al. Genetic alterations within the retinoblastoma locus in colorectal carcinomas: relation to DNA ploidy studied by flow cytometric analysis. Int J Cancer 1991; 64: 47580.